Jane Street Group, LLC Electro Core, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.21 - $0.36 $3,856 - $6,611	18,366 Added 139.78%	31,505 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $0.68 $1,370 - $2,025	2,979 Added 29.32%	13,139 $5,000
Q2 2022 Aug 16, 2022	BUY	$0.27 - $0.61 $2,743 - $6,197	10,160 New	10,160 $5,000
Q4 2021 Feb 15, 2022	SELL	$0.58 - $1.09 $15,796 - $29,686	-27,235 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$0.93 - $1.18 $25,328 - $32,137	27,235 New	27,235 $31,000

Q3 2020 Nov 17, 2020	SELL	$0.8 - $2.33 $47,548 - $138,483	-59,435 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.75 - $1.29 $44,576 - $76,671	59,435 New	59,435 $49,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $445M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.